Terravia (OTCMKTS: TVIAQ) is one of 48 publicly-traded companies in the “Specialty Chemicals” industry, but how does it weigh in compared to its rivals? We will compare Terravia to related businesses based on the strength of its earnings, risk, institutional ownership, profitability, analyst recommendations, valuation and dividends.

Valuation and Earnings

This table compares Terravia and its rivals top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Terravia $18.48 million -$101.55 million 0.00
Terravia Competitors $1.91 billion $115.75 million 221.83

Terravia’s rivals have higher revenue and earnings than Terravia. Terravia is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Risk & Volatility

Terravia has a beta of 1.23, suggesting that its stock price is 23% more volatile than the S&P 500. Comparatively, Terravia’s rivals have a beta of 1.37, suggesting that their average stock price is 37% more volatile than the S&P 500.

Insider and Institutional Ownership

0.3% of Terravia shares are owned by institutional investors. Comparatively, 65.3% of shares of all “Specialty Chemicals” companies are owned by institutional investors. 10.1% of Terravia shares are owned by insiders. Comparatively, 7.4% of shares of all “Specialty Chemicals” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Terravia and its rivals, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Terravia 0 1 0 0 2.00
Terravia Competitors 175 1073 1348 24 2.47

Terravia presently has a consensus target price of $1.50, indicating a potential upside of 37,400.00%. As a group, “Specialty Chemicals” companies have a potential downside of 0.60%. Given Terravia’s higher probable upside, equities analysts plainly believe Terravia is more favorable than its rivals.

Profitability

This table compares Terravia and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Terravia -413.48% N/A -61.89%
Terravia Competitors -639.67% -5.13% 0.46%

Summary

Terravia rivals beat Terravia on 8 of the 12 factors compared.

Terravia Company Profile

Solazyme, Inc. creates renewable oils and bioproducts. The Company’s technology uses microalgae in an industrial fermentation process to transform a range of plant-based sugars into triglyceride oils and other bioproducts. The Company offers Algenist, a skin and personal care product available at Sephora S.A. and its affiliates, QVC, Inc., SpaceNK Limited, select Nordstrom stores and ULTA Beauty. It offers intermediates/ingredients, such as Tailored oils, powdered oils, and other closely related products targeted at customers in the industrial products, food products and personal care products markets. The Company’s commercial focus is to sell oils, encapsulated oils and whole algal powdered products to companies that use them as intermediates and ingredients.

Receive News & Ratings for Terravia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Terravia and related companies with MarketBeat.com's FREE daily email newsletter.